Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.19 USD | +2.62% | -6.68% | -55.11% |
15/05 | Cabaletta Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
22/03 | HC Wainwright Adjusts Cabaletta Bio's Price Target to $30 From $25, Maintains Buy Rating | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
492M | - | - | - | - | - | |
118B | ||||||
106B | ||||||
24.28B | - | |||||
21.96B | - | |||||
18.16B |
- Stock Market
- Equities
- CABA Stock
- Charts Cabaletta Bio, Inc.
- Sector Chart